Hacker Ulrich T相关文献与解析，生知库 | 链接生命科学的每一步

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)

血浆 EBV DNA 作为 EBV 相关胃癌的预后因素：一项多中心前瞻性研究（EBV PRESAGE 研究）

doi:10.3389/fonc.2023.1276138

Alberti, Andrea; Stocker, Gertraud; Lordick, Florian; Hacker, Ulrich T; Kobitzsch, Benjamin; Haffner, Ivonne; Baiocchi, Gian Luca; Zamparini, Manuel; Tiberio, Guido A M; Baronchelli, Carla; Caruso, Arnaldo; Bossi, Paolo; Berruti, Alfredo

Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients

与脂肪酸氧化能力相关的生物标志物可预测恶病质癌症患者的持续体重下降

期刊:Journal of Cachexia Sarcopenia and Muscle

影响因子:9.1

doi:10.1002/jcsm.12817

Catanese, Silvia; Beuchel, Carl Friedrich; Sawall, Teresa; Lordick, Florian; Brauer, Rommy; Scholz, Markus; Ceglarek, Uta; Hacker, Ulrich T

Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View

从临床和转化角度探讨胃癌治疗的分子靶点及其未来展望

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers13205216

Körfer, Justus; Lordick, Florian; Hacker, Ulrich T

Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses

肿瘤微环境中的细胞焦亡和坏死性细胞死亡及其刺激抗肿瘤免疫反应的潜力

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2021.731598

Scarpitta, Allan; Hacker, Ulrich T; Büning, Hildegard; Boyer, Olivier; Adriouch, Sahil

Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial

EXPAND试验中体成分参数在胃癌/胃食管交界处癌患者预后中的作用

期刊:Journal of Cachexia Sarcopenia and Muscle

影响因子:9.1

doi:10.1002/jcsm.12484

Hacker, Ulrich T; Hasenclever, Dirk; Linder, Nicolas; Stocker, Gertraud; Chung, Hyun-Cheol; Kang, Yoon-Koo; Moehler, Markus; Busse, Harald; Lordick, Florian

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives

腺相关病毒（AAV）载体在癌症基因治疗中的临床应用：现状与展望

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers12071889

Hacker, Ulrich T; Bentler, Martin; Kaniowska, Dorota; Morgan, Michael; Büning, Hildegard

Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors.

自噬决定了腺相关病毒载体靶向肝脏基因治疗的效率

期刊:Hepatology

影响因子:15.8

doi:10.1002/hep.29176

HÃ¶sel Marianna, Huber Anke, Bohlen Susanne, Lucifora Julie, Ronzitti Giuseppe, Puzzo Francesco, Boisgerault Florence, Hacker Ulrich T, Kwanten Wilhelmus J, KlÃ¶ting Nora, BlÃ¼her Matthias, Gluschko Alexander, Schramm Michael, UtermÃ¶hlen Olaf, Bloch Wilhelm, Mingozzi Federico, Krut Oleg, BÃ¼ning Hildegard

Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.

评估血管生成素-2作为胃癌生物标志物的价值：随机 III 期 AVAGAST 试验的结果

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/bjc.2016.30

Hacker Ulrich T, Escalona-Espinosa Laura, Consalvo Nicola, Goede Valentin, Schiffmann Lars, Scherer Stefan J, Hedge Priti, Van Cutsem Eric, Coutelle Oliver, BÃ¼ning Hildegard

Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity

基因转移优先选择MHC I类阳性肿瘤细胞，并增强肿瘤免疫原性。

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-005-0035-4

Hacker, Ulrich T; Schildhauer, Ines; Barroso, Margarita Céspedes; Kofler, David M; Gerner, Franz M; Mysliwietz, Josef; Buening, Hildegard; Hallek, Michael; King, Susan B S

On the way to developing AAV-based vaccines as novel tools for cancer immunotherapy

在将基于腺相关病毒（AAV）的疫苗开发为癌症免疫治疗新型工具的道路上

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)

血浆 EBV DNA 作为 EBV 相关胃癌的预后因素：一项多中心前瞻性研究（EBV PRESAGE 研究）

Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients

与脂肪酸氧化能力相关的生物标志物可预测恶病质癌症患者的持续体重下降

Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View

从临床和转化角度探讨胃癌治疗的分子靶点及其未来展望

Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses

肿瘤微环境中的细胞焦亡和坏死性细胞死亡及其刺激抗肿瘤免疫反应的潜力

Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial

EXPAND试验中体成分参数在胃癌/胃食管交界处癌患者预后中的作用

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives

腺相关病毒（AAV）载体在癌症基因治疗中的临床应用：现状与展望

Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors.

自噬决定了腺相关病毒载体靶向肝脏基因治疗的效率

Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.

评估血管生成素-2作为胃癌生物标志物的价值：随机 III 期 AVAGAST 试验的结果

Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity

基因转移优先选择MHC I类阳性肿瘤细胞，并增强肿瘤免疫原性。